Navigation Links
Pegloticase BLA Filing Accepted for Priority Review by FDA
Date:12/29/2008

more effective products by competitors; reliance on third parties to manufacture, market and distribute many of our products; economic, political and other risks associated with foreign operations; risks of maintaining protection for our intellectual property; risks of an adverse determination in ongoing or future intellectual property litigation; and risks associated with stringent government regulation of the biopharmaceutical industry and other important factors set forth more fully in our reports filed with the Securities and Exchange Commission, to which investors are referred for further information. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements which speak only as of the date of publication of this press release to shareholders. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments that we may make. We do not have a policy of updating or revising forward-looking statements and, except as required by law, assume no obligation to update any forward-looking statements.

SVNT-I

    Contact:
    Mary Coleman                     Kelly Sullivan/Ed Trissel
    Savient Pharmaceuticals, Inc.    Joele Frank, Wilkinson Brimmer Katcher
    information@savient.com          ksullivan@joelefrank.com
    (732) 418-9300                   etrissel@joelefrank.com
                                     (212) 355-4449


'/>"/>
SOURCE Savient Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
2. Barrs BLA for Adenovirus Type 4 and 7 Live Oral Vaccines Accepted for Filing by FDA
3. Accuray Receives Nasdaq Notification Related to the Late Filing of Form 10-Q
4. Watson Announces the NDA for a 6-Month Formulation of TRELSTAR(R) Accepted for Filing by FDA for the Treatment of Advanced Prostate Cancer
5. Debiopharm Announces U.S. NDA Filing of Trelstar(R) 6-Month Formulation for Locally Advanced or Metastatic Prostate Cancer
6. KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
7. Corporate Parent Hospital Partners of America Files Voluntary Chapter 11 Petition; Filings do not Include any Hospital Facilities
8. VaxGen Provides Financial Update Following the Filing of Its 10-Q for Second Quarter With SEC; Results Include $8.5 Million Charge in Respect of Manufacturing Plant Asset Impairment
9. Wound Management Technologies, Inc. Announces Filing of a 510K
10. Digestive Care, Inc. Announces the Filing of the First Module of NDA Submission for PANCRECARB(R) (pancrelipase)
11. Statement Regarding the Filing of Signatures to Put the Human Embryo Stem Cell Issue on the November Statewide Ballot
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... Wisconsin (PRWEB) July 23, 2014 QueenBeeTickets.com is ... which is a coup for rock music fans who are ... online ticket buyers visit the site, they can use promo ... Click Here to view the inventory of discounted ... U.S. cities in August, September and October, with The Eagles ...
(Date:7/23/2014)... 23, 2014 There is inherently nothing ... that it is healthy enough to react to specific ... “washing out” harmful toxins and bacteria from the body ... body just cannot do. , However, the social ... commonly known as “excessive sweating”—are serious: since sweating itself ...
(Date:7/23/2014)... Online medical service provider MeMD has appointed ... Dr. Lorenzo joins the MeMD executive team with over ... a part of this remote treatment model, telemedicine. This is ... in medical school, that someday we could treat people across ... here and it hasn't been that long,” says Dr. Lorenzo. ...
(Date:7/23/2014)... 23, 2014 Once viewed with suspicion ... hospice has become a $14 billion-a-year business and arguably ... In Changing the Way We Die , award-winning ... means to today’s aging population and their families. It’s ... the hospice landscape, reporting the stories of patients, caregivers ...
(Date:7/23/2014)... Picnic Lunches, Residents of The Clare can now ... festivals, while still dining on the fabulous cuisine of Chef ... park or to the beach or museum and we love ... they’re out,” said Brian Hughes, director of dining services for ... just loving.” , Hagopian, the executive chef of The Clare ...
Breaking Medicine News(10 mins):Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 3Health News:Dealing with Loss: Library Journal Calls Changing the Way We Die an Essential Read 2Health News:Chicago’s The Clare Retirement Community Announces New Summertime Culinary Programs 2
... A team of experts criticized Food and Drug Administration ... safety of new drugs and take action promptly for ... will strengthen the discussion on the safety of the ... supervision. A serious discussion began in September 2004 when ...
... in the September issue of Alzheimer’s Disease and ... Florida’s Louis de la Parte Florida Mental Health// ... Policy and the School of Aging Studies report ... (ChE-Is) may delay placement into nursing homes and ...
... revive the thorny issue of making a one-year rural stint ... ,A proposal on the issue would be drafted ... reporters after the second meeting of the ministerial steering group ... December we hope to go to the cabinet for clearance ...
... United Kingdom is being nudged by a Swiss organization to ... that it can be considered for patients// suffering chronic mental ... Ludwig Minelli at the helm, is petitioning the Swiss Supreme ... "The question for politicians in Britain today is why do ...
... deterioration of Hong Kong’s air quality has resulted in increasing ... ,The deterioration of Hong Kong’s air quality has ... breathing problems. , , ,Researchers at Hong ... as sulphur dioxide, nitrogen dioxide and ozone of about three ...
... limit to the curiosity of researchers to unravel the potential ... to the origin of response to// fear, is a specific ... at the end of the tunnel for those in the ... ,Scientists used a fairly easy examination along with magnetic resonance ...
Cached Medicine News:Health News:Appraisal of FDA’s Drug Safety Proces 2Health News:Appraisal of FDA’s Drug Safety Proces 3Health News:Drug May Delay Nursing Home Placement for Dementia Patients 2Health News:Compulsory Rural Stint for Doctors: Ramadoss 2Health News:Fearful or Fearless, Control Exists in The Brain 2
(Date:7/22/2014)... July 22, 2014  Edwards Lifesciences Corporation (NYSE: ... of heart valves and hemodynamic monitoring, announced that Edwards, ... served as an expert panelist at the invitation of ... Health to discuss medical device innovation at its hearing, ... Evidence Development and Communication." "Edwards has five ...
(Date:7/22/2014)... 22, 2014  Jazz Pharmaceuticals plc (Nasdaq: ... 2014 second quarter financial results on Tuesday, August 5, ... management will host a live audio webcast immediately following ... provide a business and financial update and discuss second ... access the live audio webcast via the Investors & ...
(Date:7/22/2014)... July 22, 2014 Research and Markets ... Culture Market by Equipment, by Reagent, by Application - ... http://photos.prnewswire.com/prnh/20130307/600769 ... culture is one of the most important and widely ... largest application segment of the cell culture market in ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3
The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump....
... a minimally invasive, highly effective surgical alternative ... GYNECARE TVT is positioned close to the ... when needed, TVT provides tension-free support of ... procedure takes approximately 20 to 30 minutes, ...
... best of both worlds, the PeaceKeeper ... the latest addition to the Wet-Field ... cautery instruments for ophthalmic surgery. Combining ... aspiration and backflush functionality in a ...
...
Medicine Products: